Zobrazeno 1 - 10
of 28
pro vyhledávání: '"David J. Schenk"'
Publikováno v:
Journal of Labelled Compounds and Radiopharmaceuticals. 59:391-397
Speeding the analysis of reaction aliquots, high-performance liquid chromatography (HPLC) fractions and final products continue to be an area of great interest in the study of radiopharmaceuticals. Translating recently developed rapid HPLC and ultra
Autor:
Elizabeth Joshi, Zhizhen Zeng, Joseph Della Rocca, David J. Schenk, Jeffrey L. Evelhoch, Idriss Bennacef, Abbas Walji, Hyking Haley, Mona Purcell, Kerry Riffel, Serena Xu, Marie A. Holahan, Paul J. Coleman, Eric D. Hostetler, Talakad G. Lohith, Aileen Soriano, Brett Connolly, Liza Gantert, Patricia Miller, Cristian Salinas, Xiaoping Zhang, Aimie Ogawa, David Hesk
Publikováno v:
Journal of Nuclear Medicine. 57:1599-1606
A PET tracer is desired to help guide the discovery and development of disease-modifying therapeutics for neurodegenerative diseases characterized by neurofibrillary tangles (NFTs), the predominant tau pathology in Alzheimer disease (AD). We describe
Autor:
Patricia Miller, Yaode Wang, Joseph Della Rocca, Jeffrey L. Evelhoch, Paul J. Coleman, Kerry Riffel, Zhizhen Zeng, Elizabeth Joshi, Kun Yang, Xiaoping Zhang, Kerim Babaoglu, Eric D. Hostetler, Talakad G. Lohith, Stacey O'Malley, David Hesk, Abbas Walji, Jaume Balsells, Mona Purcell, Jing Li, Serena Xu, Brett Connolly, Stacey Melquist, Arie Struyk, Jianmin Fu, Julie A. O'Brien, Marie A. Holahan, Harold G. Selnick, Fred Hess, Aimie Ogawa, David J. Schenk, Idriss Bennacef, Cristian Salinas, Joel B. Schachter, Aileen Soriano, Liza Gantert
Publikováno v:
Journal of Medicinal Chemistry. 59:4778-4789
Neurofibrillary tangles (NFTs) made up of aggregated tau protein have been identified as the pathologic hallmark of several neurodegenerative diseases including Alzheimer's disease. In vivo detection of NFTs using PET imaging represents a unique oppo
Publikováno v:
Journal of Labelled Compounds and Radiopharmaceuticals. 59:136-146
When the isotopic abundance or specific activity of a labeled compound is determined by mass spectrometry (MS), it is necessary to correct the raw MS data to eliminate ion intensity contributions, which arise from the presence of heavy isotopes at na
Autor:
Scott R. Pollack, David J. Schenk
Publikováno v:
Journal of Labelled Compounds and Radiopharmaceuticals. 58:433-441
Omeprazole (Prilosec®) is a selective and irreversible proton pump inhibitor used to treat various medical conditions related to the production of excess stomach acids. It functions by suppressing secretion of those acids. Radiolabeled compounds are
Publikováno v:
Journal of Labelled Compounds and Radiopharmaceuticals. 58:291-298
Compounds containing tritium are widely used across the drug discovery and development landscape. These materials are widely utilized because they can be efficiently synthesized and produced at high specific activity. Results from internally calibrat
Autor:
Jeffrey C. Moore, Nelo R. Rivera, David J. Schenk, Heather Wang, Ingrid Mergelsberg, David Hesk
Publikováno v:
Tetrahedron Letters. 57:1090-1092
Isotopically labeled compounds have numerous applications in drug discovery and development. (R)-9-(2-Hydroxypropyl)adenine 1 is an important intermediate in the synthesis of various acyclic nucleoside phosphonates including tenofovir. We have develo
Autor:
Brett Connolly, Jeffrey L. Evelhoch, Wenping Li, David J. Schenk, Zhizhen Zeng, Talakad G. Lohith, James Mulhearn, Stacey O'Malley, David Hesk, Idriss Bennacef, Eric D. Hostetler, Patricia Miller, Abbas Walji, Cyrille Sur
Publikováno v:
Alzheimer's & Dementia. 13
Autor:
Zhizhen Zeng, Patricia J. Miller, Brett M. Connolly, Stacey S. O'Malley, Talakad Lohith, Idriss Bennacef, James Mulhearn, David J. Schenk, David Hesk, Abbas Walji, Cyrille Sur, Wenping Li, Eric D. Hostetler, Jeffrey Evelhoch
Publikováno v:
Alzheimer's & Dementia. 13
Publikováno v:
Journal of Labelled Compounds and Radiopharmaceuticals. 57:645-651
The specific activity (SA) values determined using two different methods were compared for a set of tritium-labeled and carbon-14-labeled compounds. The methods employed were as follows: (a) liquid chromatography/mass spectrometry (LC/MS) isotopic pe